Donald Trump said that on Sunday he had signed a new executive order aimed at lowering drug prices in the United States, linking them with other countries.
‘My favorite nation order will ensure that our country gets the same low price that Big Pharma gives to other countries. “The days of global freedom at the expense of America are over,” Trump said in a Twitter post.
He said: ‘Also abolished all exemptions for middlemen, reducing prices further.’
In July, the president signed an executive order requiring, inter alia, that Medicare would be required to tie the prices paid by those countries to drugs paid by other countries. However, its implementation was delayed, as the administration sought to work out a solution with the industry.
It was unclear if Trump signed a new order or was referring to the document, which was also referred to as a Most-Preferred-Nation Executive Order.
Trump signed four executive orders designed to reduce drug costs for consumers in a bid to highlight a commitment to cut prescription prices ahead of three executive elections in July.
Orders were issued ranging from relaxation of drug distribution rules to dispensing of medicines to manufacturers, but experts said they were unlikely to be effective in the near term. Similar proposals by the Trump administration prohibited the industry’s pushback.
Donald Trump said on Sunday that he had signed a new executive order aimed at lowering drug prices in the United States, connecting him to those other nations
‘My favorite nation order will ensure that our country gets the same low price that Big Pharma gives to other countries. “The days of global freedom are over at America’s expense,” Trump said Sunday in a Twitter post. The president is pictured in a Latino to Trump alliance Sunday at the Treasure Coalition Hotel and Casino
Trump took his July directives as far-reaching, but they mostly update the administration’s views that have not yet taken effect.
Promising ‘large-scale’ savings at the signed ceremony, he said, ‘I am irrigating a system that is several decades old.’
Trump complained that the drug companies were ‘getting away with the murder’ and promised to get them under control. Nearly four years later, despite some recent moderation of price increases, things are very similar.
A few days after signing the executive order in July, Trump accused the pharmaceutical industry of running advertisements that lied about his new executive order for reduced drug spending.
The allegations came after industry officials refused to attend a meeting with the president at the White House to discuss the matter.
Trump tweeted: ‘Big Pharma is taking a TV advertisement in this case that I am increasing the price of medicines on seniors. Advertising is a lie! What I have done will reduce prices by 50%, at least, and Big Pharma is not happy about it.
‘No other president will be able to do what I have. So when you miss those naughty commercials from Big Pharma, there’s only one reason they’re all going out, the massive price deficiencies you’re getting – not good for them. Also, I was the President in only 51 years who got the prescription D! ‘
President Donald Trump signed executive orders on prescription drug prices in the South House Auditorium on July 24 at the White House
The major law-making campaign came to a standstill in the Congress this year. Although Trump told Republican senators that reducing prescription prices is ‘something you have to do’, many remain reluctant to use federal authority to force drugmakers to charge less.
Congressional Democrats, meanwhile, calculated that the election would strengthen their hand, and they would eventually be able to enact a law that authorized Medicare to negotiate prices directly. Neither party in Congress has received an impetus for the agreement, and the White House has been unable to fulfill Trump’s will.
Americans remain concerned about drug costs, with 9 out of 10 in a recent Gallup-West Health poll saying they are worried that the pharmaceutical industry will take advantage of the coronovirus epidemic.
Drug makers remained adamant against government efforts to curb prices.
Experts said that no order was likely to go into effect in the near term. Similar proposals by the Trump administration prohibited the industry’s pushback.
The head of the pharmaceutical lobby, Stephen Ubl, said that Trump’s administration has decided to adopt a radical and dangerous policy to price based on the rates paid in countries that he has dubbed socialist, which today and the future Will harm patients. a statement.
Trump described his directives as far-reaching, but they mostly update the views of earlier administrations that have not yet taken effect; Trump signs an executive order on July 24 at the White House in Washington DC to lower drug prices